Biocure Technology Inc.
Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.
Biocure Technology Inc. (CURE)
Communiqués de presse
le 28 novembre/November 2017
Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.
Listing and disclosure documents will be available at thecse.com on the trading date.